Tela Bio Stock Investor Sentiment

TELA Stock  USD 1.99  0.02  1.00%   
About 71 percent of all Tela Bio's investors are curious in acquiring. The analysis of overall sentiment of trading Tela Bio stock suggests that a large number of investors are confidant at this time. The current market sentiment, together with Tela Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Tela Bio stock news signals to limit their universe of possible portfolio assets.

Comfort Level 71

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Tela Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Tela Bio.

Tela Historical Sentiment

Although Tela Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Tela, such as negative comments on social media and news outlets, may cause fear in the market and push Tela Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Tela.

Tela Bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Tela Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tela Bio Historical Investor Sentiment

Investor biases related to Tela Bio's public news can be used to forecast risks associated with an investment in Tela. The trend in average sentiment can be used to explain how an investor holding Tela can time the market purely based on public headlines and social activities around Tela Bio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tela Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tela Bio and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Tela Bio news discussions. The higher the estimate score, the more favorable the investor's outlook on Tela Bio.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Tela Bio's Stock prices. Below is the latest headlines and news related to Tela Bio Stock. The global stock market is bearish. About 68% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Tela Bio that are available to investors today. This information is accessible both publicly - through Tela Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Tela-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Tela Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tela Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tela Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tela Bio alpha.

Tela Largest EPS Surprises

Earnings surprises can significantly impact Tela Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-05-07
2025-03-31-0.2075-0.25-0.042520 
2021-03-24
2020-12-31-0.49-0.54-0.0510 
2020-08-12
2020-06-30-0.59-0.530.0610 
2023-08-09
2023-06-30-0.53-0.460.0713 
2023-05-11
2023-03-31-0.56-0.63-0.0712 
2020-05-12
2020-03-31-0.56-0.63-0.0712 
View All Earnings Estimates
over a week ago at finance.yahoo.com         
Breakeven On The Horizon For TELA Bio, Inc.
Yahoo News
over two weeks ago at news.google.com         
TELA Bio Launches OviTex Inguinal Reinforced Tissue Matrix in Europe - JD Supra
Google News at Macroaxis
over two weeks ago at news.google.com         
TELA Bio adds US9.1m to market cap in the past 7 days, though investors from five years ago are stil...
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Azarbarzin Kurt of 11700 shares of Tela Bio at 1. subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 5772 shares by Antony Koblish of Tela Bio at 2.65 subject to Rule 16b-3
Macroaxis News
over a month ago at globenewswire.com         
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
Yahoo News
over a month ago at gurufocus.com         
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635 TELA Stock News
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Cuca Roberto of 83800 shares of Tela Bio at 2.72 subject to Rule 16b-3
Macroaxis News
over a month ago at thelincolnianonline.com         
TELA Bio, Inc. Short Interest Down 13.6 percent in May
news
over a month ago at globenewswire.com         
TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguin...
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
Tela Bio Debuts OviTex Inguinal Matrix in Europe TELA Stock News
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
TELA Bio Announces European Commercial Launch of OviTex Inguina
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Acquisition by Jeffrey Blizard of 104800 shares of Tela Bio subject to Rule 16b-3
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Tela Bio that are available to investors today. This information is accessible both publicly - through Tela Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Tela-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Tela Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tela Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tela Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tela Bio alpha.

Tela Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Q1 2025 TELA Bio Inc Earnings Call Transcript
05/09/2025
2
Investors Still Arent Entirely Convinced By TELA Bio, Inc.s Revenues Despite percent Price Jump
05/21/2025
3
Acquisition by Colleran Lisa N of 11700 shares of Tela Bio at 1. subject to Rule 16b-3
05/28/2025
4
Disposition of 190 shares by Paul Talmo of Tela Bio at 1.22 subject to Rule 16b-3
05/29/2025
5
Acquisition by Jeffrey Blizard of 104800 shares of Tela Bio subject to Rule 16b-3
06/02/2025
6
TELA Bio Announces European Commercial Launch of OviTex Inguina
06/03/2025
7
Acquisition by Cuca Roberto of 83800 shares of Tela Bio at 2.72 subject to Rule 16b-3
06/05/2025
8
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
06/06/2025
9
Acquisition by Azarbarzin Kurt of 11700 shares of Tela Bio at 1. subject to Rule 16b-3
06/20/2025
10
Breakeven On The Horizon For TELA Bio, Inc.
07/02/2025

Complementary Tools for Tela Stock analysis

When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.